The Plan Sponsor's Guide to Rare Diseases
When it comes to rare diseases, plan sponsors need to strike the appropriate balance between the urgency to respond to plan members’ healthcare needs with the uncertainty, financial impact, affordability and plan sustainability related to reimbursing drugs for rare diseases. This guide will help plan sponsors understand rare diseases and how they can impact plan members who live with them or who are caregivers to family members. It will also examine the challenges patients face in getting an accurate diagnosis and accessing appropriate treatment. Click below to read the full guidebook.